GSK vs ULCC · P/E 13, $103.31B cap vs rev $3.72B
GlaxoSmithKline PLC ADR (GSK) versus Frontier Group Holdings Inc (ULCC) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Frontier Group Holdings Inc (ULCC) is a airlines company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported ULCC revenue for 2025-12-31 was $3.72B. Net income was -$137.0M. Revenue was down 1.4% from 2024-12-31 to 2025-12-31. ULCC currently screens at market cap $1.53B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. ULCC currently screens at market cap $1.53B.
Not investment advice. Open the GSK and ULCC stock pages for the full models.
Not investment advice.